All In MedTech

Device Trial Radar · NCT05808699

Camera Qualification Study

Camera Qualification of an Additional Fundus Camera Paired With An Autonomous AI for Detecting Diabetic Retinopathy

Last checked: Nov 19, 2026Latest source record: Oct 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

626

Actual

Start

Mar 3, 2023

Primary completion

Nov 30, 2023

Study completion Jan 30, 2025

Sponsor

Lead sponsor
Digital Diagnostics, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Laboratory Corporation of America
First posted
Apr 11, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.

Conditions

  • Diabetic Retinopathy

Interventions

  • handheld fundus cameraDevice

    Fundus camera

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and Specificity Corrected for EnrichmentTime frame: Day 1

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Infinity Clinical Research

    Norco, California

  • Dream Team

    Pomona, California

  • East Cost Institute for Research

    Jacksonville, Florida

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.